scispace - formally typeset
A

Afrânio Lineu Kritski

Researcher at Federal University of Rio de Janeiro

Publications -  216
Citations -  3852

Afrânio Lineu Kritski is an academic researcher from Federal University of Rio de Janeiro. The author has contributed to research in topics: Tuberculosis & Mycobacterium tuberculosis. The author has an hindex of 30, co-authored 198 publications receiving 3376 citations. Previous affiliations of Afrânio Lineu Kritski include Universidade Federal de Minas Gerais.

Papers
More filters
Journal ArticleDOI

Phenotypes of lung mononuclear phagocytes in HIV seronegative tuberculosis patients: evidence for new recruitment and cell activation

TL;DR: Immunostaining the phenotype of mononuclear phagocytes obtained from lungs of patients with active tuberculosis suggests that despite recruitment of monocytes probably from the peripheral blood and local cell activation, host defense of the resident lung cells is insufficient to control M. tuberculosis.
Journal ArticleDOI

Modelling the impact of chest X-ray and alternative triage approaches prior to seeking a tuberculosis diagnosis.

TL;DR: A model for the impact assessment of alternative triage approaches for tuberculosis, with or without X-ray, based on data from Porto Alegre City, Brazil demonstrates its usefulness in informing policy in a typical high burden setting for tuberculosis.
Journal ArticleDOI

An ensemble approach for supporting the respiratory isolation of presumed tuberculosis inpatients

TL;DR: This paper proposes a novel technique for developing a committee of classifiers aiming at supporting the decision making relative to inpatient respiratory isolation, and confirms that the resulting committees have outperformed several recently proposed single-models and ensemble solutions, including deep learning techniques.
Journal ArticleDOI

Assessing new strategies for TB diagnosis in low- and middle-income countries

TL;DR: The current situation of tuberculosis globally and in Brazil, the need for new strategies toward tuberculosis control, focusing on new diagnostic technologies is reported, and critical comments are given on the state of the art regarding the evaluation of new health technologies.